PME-1 is a protein that modifies other proteins by removing methyl groups, but high levels of PME-1 are observed in some diseases, including Alzheimer's disease (AD) and cancer.

The Food and Drug Administration has approved the first blood test for diagnosing Alzheimer's disease, the agency announced ...

U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...

The U.S. Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...

The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a ...

The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other ...

Scientists at Northwestern University have developed a new approach that directly combats the progression of ...